Abstract: A varactor may include a gate electrode; a graphene layer; and a ferroelectric layer between the gate electrode and the graphene layer.

Abstract: A pinch valve configured to be combined with an inversion apparatus. An elongated component, such as a rope, cable, or light train, is able to pass through the lumen of the pinch valve during the positioning and curing of a repair assembly into an underground pipe system. A deformable member positioned within the housing is movable between a first position having a first internal diameter and a second position having a second internal diameter that is smaller than the first internal diameter. In the second position the deformable member is moved to constrict around the elongated component as the component passes through the valve. This helps prevent pressure from escaping through the pinch valve by decreasing the space between the deformable member and the elongated component. In this manner, the internal diameter of the pinch valve is able to conform to various diameters of elongated components passing through the valve in real time by moving the deformable member to create the desired internal diameter.

Abstract: A pinch valve configured to be combined with an inversion apparatus. An elongated component, such as a rope, cable, or light train, is able to pass through the lumen of the pinch valve during the positioning and curing of a repair assembly into an underground pipe system. A deformable member positioned within the housing is movable between a first position having a first internal diameter and a second position having a second internal diameter that is smaller than the first internal diameter. In the second position the deformable member is moved to constrict around the elongated component as the component passes through the valve. This helps prevent pressure from escaping through the pinch valve by decreasing the space between the deformable member and the elongated component. In this manner, the internal diameter of the pinch valve is able to conform to various diameters of elongated components passing through the valve in real time by moving the deformable member to create the desired internal diameter.

Abstract: A proxy system is installed on a computing device that is in the network path between the device and the Internet. The proxy system, residing on the computing device, decrypts and inspects all traffic going in and out of the computing device.

Abstract: A method and apparatus for repairing a pipeline. The apparatus includes a liner assembly made of resin absorbent material. The liner assembly is configured to be impregnated with a light-activated resin. The apparatus also includes a bladder assembly configured to expand to press the main liner member against the interior wall of the pipeline and a lighting assembly configured to provide light at the wavelength which initiates curing of the light-activated resin.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for receiving, from a user device, a request to include financial data describing a financial account in an interface, the financial account being associated with a particular financial institution; identifying one or more metadata attributes for accessing the financial account associated with the particular financial institution; obtaining a public digital key associated with the financial institution; providing, to the user device, data describing the one or more metadata attributes and the public digital key associated with the financial institution; receiving, from the user device, respective values for the one or more metadata attributes, the corresponding values having been encrypted by the user device using the public digital key; and storing the encrypted values for the one or more metadata attributes for use in accessing and aggregating financial data describing the financial account.

Abstract: A proxy system is installed on a computing device that is in the network path between the device and the Internet. The proxy system, residing on the computing device, decrypts and inspects all traffic going in and out of the computing device.

Abstract: The present invention relates to the field of pharmacy, particularly to a pharmaceutical composition for oral administration comprising an (a) inert substrate and a (b) mixture comprising a non-bile acid farnesoid X receptor (FXR) agonist, such as 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid, or a pharmaceutically acceptable salt thereof, and at least one binder. The present invention also relates to a process for preparing said pharmaceutical composition for oral administration; and to the use of said pharmaceutical composition in the manufacture of a medicament.

Abstract: A proxy system is installed on a computing device that is in the network path between the device and the Internet. The proxy system, residing on the computing device, decrypts and inspects all traffic going in and out of the computing device.

Abstract: The present invention relates to the field of pharmacy, particularly to a pharmaceutical composition for oral administration comprising an (a) inert substrate and a (b) mixture comprising a non-bile acid farnesoid X receptor (FXR) agonist, such as 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid, or a pharmaceutically acceptable salt thereof, and at least one binder. The present invention also relates to a process for preparing said pharmaceutical composition for oral administration; and to the use of said pharmaceutical composition in the manufacture of a medicament.

Abstract: A proxy system is installed on a computing device that is in the network path between the device and the Internet. The proxy system, residing on the computing device, decrypts and inspects all traffic going in and out of the computing device.

Abstract: Disclosed are novel pharmaceutical formulation containing 3?-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2?-hydroxy-[1,1?-biphenyl]-3-carboxylic acid or a pharmaceutically acceptable salt thereof and processes for preparing the same.

Abstract: The The present invention relates to the field of pharmacy, particularly to a pharmaceutical composition for oral administration comprising an (a) inert substrate and a (b) mixture comprising a non-bile acid farnesoid X receptor (FXR) agonist, such as 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid, or a pharmaceutically acceptable salt thereof, and at least one binder. The present invention also relates to a process for preparing said pharmaceutical composition for oral administration; and to the use of said pharmaceutical composition in the manufacture of a medicament.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for receiving, from a user device, a request to include financial data describing a financial account in an interface, the financial account being associated with a particular financial institution; identifying one or more metadata attributes for accessing the financial account associated with the particular financial institution; obtaining a public digital key associated with the financial institution; providing, to the user device, data describing the one or more metadata attributes and the public digital key associated with the financial institution; receiving, from the user device, respective values for the one or more metadata attributes, the corresponding values having been encrypted by the user device using the public digital key; and storing the encrypted values for the one or more metadata attributes for use in accessing and aggregating financial data describing the financial account.

Abstract: Methods, systems, and apparatus, including computer programs encoded on computer storage media, for receiving, from a user device, a request to include financial data describing a financial account in an interface, the financial account being associated with a particular financial institution; identifying one or more metadata attributes for accessing the financial account associated with the particular financial institution; obtaining a public digital key associated with the financial institution; providing, to the user device, data describing the one or more metadata attributes and the public digital key associated with the financial institution; receiving, from the user device, respective values for the one or more metadata attributes, the corresponding values having been encrypted by the user device using the public digital key; and storing the encrypted values for the one or more metadata attributes for use in accessing and aggregating financial data describing the financial account.

Abstract: The present invention provides a method to treat sinusitis comprising (a) inserting a portion of an irrigation catheter having an expandable material in a non-expanded state endoscopically into a sinus of a patient through ostium of a sinus; (b) expand the expandable material under endoscopic visualization until it has expanded and filled some portion of the sinus without directly contacting and compressing mucosal surfaces of the sinus; (c) introducing irrigation fluid into the sinus through an irrigation lumen of the catheter to create a circumferential irrigation flow in space between the expanded material and the mucosal surface in order to dislodge and express sinus contents.

Abstract: Soluble pharmaceutical compositions of nilotinib or a pharmaceutically acceptable salt thereof were invented using one or more organic acids that function as a solubilizing agent, increasing the bioavailability of nilotinib and supressing the food effect associated with certain compositions of nilotinib. The pharmaceutical compositions are in the form of solid oral dosage forms, including capsules and tablets.

Abstract: A data processing apparatus and method has a plurality of processing units, at least one of which is configured to be switchable between an active power state and a dormant power state and the units share a memory, and at least one local storage unit is configured to store a local copy of a data item stored in the memory for access by an associated processing unit. A snoop control unit is monitors memory access requests and when one is issued, if the control unit has an indication that a local storage unit belonging to another dormant processing unit has a local copy of that data storage item and a cache coherency protocol required that the local copy of the requested data item associated with the other processing unit be invalidated, the control unit stores a marker indicating that that other local copy should later be invalidated.

Abstract: A data processing apparatus and method are provided for handling memory access requests to shared memory. The data processing apparatus has a plurality of processing units, at least one of which is configured to be switchable between an active power state and a dormant power state. The processing units share a memory, and at least one local storage unit is configured to store a local copy of a data item stored in the memory for access by an associated processing unit. A snoop control unit is configured to monitor memory access requests issued by the processing units and to store in the snoop control unit indications of local copies of data items stored in each local storage unit.

Abstract: A method of Nanoparticle-based therapy for a mammalian subject is disclosed. The method uses Nanoparticles and/or Nanoparticles with outer surfaces that contain an affinity moiety effective to bind specifically to a biological surface at which the therapy is aimed, and a hydrophilic polymer coating. The hydrophilic polymer coating is made up of polymer chains either covalently linked or surface adsorbed to the polymer components.